Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Chronic Insomnia

eicosapentaenoic acid ethyl ester has been researched along with Chronic Insomnia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, LS1
Joffe, H1
Guthrie, KA1
Ensrud, KE1
Freeman, M1
Carpenter, JS1
Learman, LA1
Newton, KM1
Reed, SD1
Manson, JE1
Sternfeld, B1
Caan, B1
Freeman, EW1
LaCroix, AZ1
Tinker, LF1
Booth-Laforce, C1
Larson, JC1
Anderson, GL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation[NCT01178892]355 participants (Actual)Interventional2010-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for eicosapentaenoic acid ethyl ester and Chronic Insomnia

ArticleYear
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:4

    Topics: Adult; Affect; Anxiety; Depression; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Aci

2014